LBO — MORRISTOWN MEDICAL CENTER
IRR: 17.2% | MOIC: 2.21x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.2%
IRR
2.21x
MOIC
$1.8B
Entry EV
$2.8B
Exit EV
$925.0M
Equity Invested
Sources & Uses
S&UTotal · $1.8B| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $698.1M | 38.8% | |
| Sub Debt | $174.5M | 9.7% | |
| Equity | $925.0M | 51.5% | |
| Enterprise Value | $1.7B | 97.1% | |
| Transaction Fees | $52.4M | 2.9% | |
| Total Uses | $1.8B | 100.0% |
Interpretation
INTAt 2.21x MOIC and 17.2% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $264.0M |
| Exit Ev | $2.8B |
| Net Debt At Exit | $726.4M |
| Equity At Exit | $2.0B |
| Equity Invested | $925.0M |
| Total Value Created | $1.1B |
| Value From Growth | $939.7M |
| Value From Multiple | $87.3M |
| Value From Deleveraging | $146.3M |